Zydus Therapeutics Inc.
Clinical trials sponsored by Zydus Therapeutics Inc., explained in plain language.
-
New hope for PBC patients: phase 3 trial targets liver enzyme levels
Disease control Not yet recruitingThis study tests a drug called saroglitazar magnesium in people with primary biliary cholangitis (PBC) who either didn't respond well to or couldn't tolerate the standard treatment, ursodeoxycholic acid. The goal is to see if the drug can lower a key liver enzyme (alkaline phosph…
Phase: PHASE3 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated May 01, 2026 21:57 UTC
-
New drug aims to delay liver failure in bile duct disease
Disease control Not yet recruitingThis study tests a drug called saroglitazar magnesium in adults with primary biliary cholangitis (PBC), a chronic liver disease. About 386 participants will receive either the drug or a placebo for several years. The goal is to see if the drug can delay serious liver problems lik…
Phase: PHASE3 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC